醫療季營收分析

最後更新 2025-09-09 08:39:22 (UTC+8)

季營收趨勢分析

醫療類股公司整體季營收成長趨勢。

醫療類股調整後季營收與 XLV ETF走勢圖

FindBillion.com

季節調整後季營收成長率


季營收季增率	5%
季營收年增率	11.1%

季營收與股價相關性分析

判斷醫療類股ETF(XLV) 股價和醫療類股整體季節調整後季營收有無相關性，若中高度相關性，可由整體季節調整後季營收推估股價是否合理。

醫療類股整體季節調整後季營收-股價散佈圖

醫療類股整體季節調整後季營收與股價高度相關，相關性越高，參考意義越大。

醫療類股整體季節調整後季營收與股價間的
決定係數

高度相關 0.89

FindBillion.com

📢

Loading Ad...

相關個股

醫療相關的個股，以及該個股的季營收季增率、年增率。

代碼	公司名稱	季營收季增率	季營收年增率
VRNA	Verona Pharma plc	2708788.8%	轉虧為盈%
CYTK	Cytokinetics, Incorporated	4501.9%	26714.9%
IONS	Ionis Pharmaceuticals, Inc.	253.3%	100.7%
ABVX	Abivax S.A.	244%	229.1%
RNA	Avidity Biosciences, Inc.	170.4%	88.1%
ARGX	argenx SE	101.8%	98.5%
ASND	Ascendis Pharma A/S	101%	339%
BNTX	BioNTech SE	74.4%	101.6%
NBIX	Neurocrine Biosciences, Inc.	67.4%	16.5%
MDGL	Madrigal Pharmaceuticals, Inc.	46.7%	1353.8%
CAI	Caris Life Sciences, Inc.	39.8%	79.9%
TEM	Tempus AI, Inc.	32.7%	89.6%
GMED	Globus Medical, Inc.	28.4%	18.4%
MRNA	Moderna, Inc.	27.2%	-35.7%
ALNY	Alnylam Pharmaceuticals, Inc.	26.4%	17.3%
AXSM	Axsome Therapeutics, Inc.	25.9%	72.1%
INSM	Insmed Incorporated	22.6%	18.9%
CORT	Corcept Therapeutics Incorporated	18.3%	18.7%
RYTM	Rhythm Pharmaceuticals, Inc.	17.5%	66.8%
LLY	Eli Lilly and Company	17.3%	37.6%
EXAS	Exact Sciences Corporation	16.3%	16%
NTRA	Natera, Inc.	14.2%	32.2%
HALO	Halozyme Therapeutics, Inc.	13.3%	40.8%
PODD	Insulet Corporation	11.8%	32.9%
DOCS	Doximity, Inc.	11.6%	15.2%
BMRN	BioMarin Pharmaceutical Inc.	11.4%	15.9%
VRTX	Vertex Pharmaceuticals Incorporated	11.3%	12.1%
RPRX	Royalty Pharma plc	10.8%	7.7%
GSK	GSK plc	10.4%	1.3%
BIO	Bio-Rad Laboratories, Inc.	10.3%	2.1%
ZBH	Zimmer Biomet Holdings, Inc.	10.2%	7%
EW	Edwards Lifesciences Corporation	10%	10.6%
MEDP	Medpace Holdings, Inc.	9.9%	14.2%
LH	Labcorp Holdings Inc.	9.6%	9.5%
REGN	Regeneron Pharmaceuticals, Inc.	9.5%	3.6%
GH	Guardant Health, Inc.	9.5%	30.9%
ONC	BeOne Medicines Ltd.	9%	41.6%
ALC	Alcon Inc.	9%	4%
AZN	AstraZeneca PLC	8.8%	11.7%
BMY	Bristol-Myers Squibb Company	8.8%	0.6%
ATR	AptarGroup, Inc.	8.4%	6.1%
JAZZ	Jazz Pharmaceuticals plc	8.4%	2.1%
ELAN	Elanco Animal Health Incorporated	8.3%	4.8%
PFE	Pfizer Inc.	8.1%	10.3%
INCY	Incyte Corporation	8%	16.5%
ABBV	AbbVie Inc.	7.8%	6.6%
ZTS	Zoetis Inc.	7.8%	4.2%
ABT	Abbott Laboratories	7.7%	7.4%
IQV	IQVIA Holdings Inc.	7.6%	5.3%
HLN	Haleon plc	7.3%	-0.3%
HOLX	Hologic, Inc.	7.2%	1.2%
BSX	Boston Scientific Corporation	7.2%	22.8%
IDXX	IDEXX Laboratories, Inc.	7%	10.6%
CAH	Cardinal Health, Inc.	6.9%	0.8%
ISRG	Intuitive Surgical, Inc.	6.9%	21.4%
BDX	Becton, Dickinson and Company	6.9%	10.4%
JNJ	Johnson & Johnson	6.7%	5.8%
TEVA	Teva Pharmaceutical Industries Limited	6.7%	0.3%
RGEN	Repligen Corporation	6.7%	18.4%
WAT	Waters Corporation	6.2%	8.9%
AMGN	Amgen Inc.	6%	9.3%
QGEN	Qiagen N.V.	6%	7.5%
WST	West Pharmaceutical Services, Inc.	5.9%	9.1%
PEN	Penumbra, Inc.	5.9%	13.4%
TMO	Thermo Fisher Scientific Inc.	5.9%	3%
MCK	McKesson Corporation	5.8%	23.4%
ENSG	The Ensign Group, Inc.	5.3%	18.5%
UHS	Universal Health Services, Inc.	5.2%	9.6%
DGX	Quest Diagnostics Incorporated	5.1%	15.2%
ICLR	ICON Public Limited Company	5.1%	-4.8%
COR	Cencora, Inc.	4.8%	8.7%
HSIC	Henry Schein, Inc.	4.8%	3.3%
VTRS	Viatris Inc.	4.5%	-5.6%
THC	Tenet Healthcare Corporation	4.5%	3.3%
CVS	CVS Health Corporation	4.3%	8.4%
HQY	HealthEquity, Inc.	4.2%	8.6%
STVN	Stevanato Group S.p.A.	4.2%	7.9%
HCA	HCA Healthcare, Inc.	3.9%	6.4%
ALGN	Align Technology, Inc.	3.9%	-1.6%
GRFS	Grifols, S.A.	3.8%	4%
MTD	Mettler-Toledo International Inc.	3.8%	3.9%
A	Agilent Technologies, Inc.	3.8%	10.1%
CNC	Centene Corporation	3.6%	22.4%
GILD	Gilead Sciences, Inc.	3.6%	1.8%
BIIB	Biogen Inc.	3.5%	7.3%
ILMN	Illumina, Inc.	3.5%	-4.8%
UNH	UnitedHealth Group Incorporated	3.4%	14.1%
RVTY	Revvity, Inc.	3.3%	4.1%
RDY	Dr. Reddy's Laboratories Limited	3.3%	11.4%
MOH	Molina Healthcare, Inc.	3.2%	15.7%
HUM	Humana Inc.	3.1%	9.6%
SYK	Stryker Corporation	3%	11.1%
MRK	Merck & Co., Inc.	2.9%	-1.9%
STE	STERIS plc	2.8%	8.7%
BAX	Baxter International Inc.	2.8%	4.3%
GEHC	GE HealthCare Technologies Inc.	2.7%	3.5%
MDT	Medtronic plc	2.6%	8.4%
VEEV	Veeva Systems Inc.	2.4%	16.7%
COO	The Cooper Companies, Inc.	2.3%	5.7%
NVO	Novo Nordisk A/S	1.9%	12.9%
ELV	Elevance Health Inc.	1.8%	14%
DXCM	DexCom, Inc.	1.7%	15.2%
SOLV	Solventum Corporation	1.6%	3.8%
NVS	Novartis AG	1.5%	14.1%
EHC	Encompass Health Corporation	1.4%	12%
WBA	Walgreens Boots Alliance, Inc.	1.4%	7.2%
RMD	ResMed Inc.	1.2%	10.2%
DVA	DaVita Inc.	1.2%	6.1%
SNY	Sanofi	1.1%	-5.7%
PHG	Koninklijke Philips N.V.	1.1%	-2.8%
TECH	Bio-Techne Corporation	0.1%	3.5%
CRL	Charles River Laboratories International, Inc.	0.1%	0.6%
SNN	Smith & Nephew plc	-0.7%	9.3%
MASI	Masimo Corporation	-2.5%	7.9%
CHE	Chemed Corporation	-3.5%	3.8%
TAK	Takeda Pharmaceutical Company Limited	-3.8%	-8.4%
DHR	Danaher Corporation	-3.8%	3.4%
FMS	Fresenius Medical Care AG & Co. KGaA	-4.2%	0.5%
UTHR	United Therapeutics Corporation	-7%	11.7%
EXEL	Exelixis, Inc.	-10.2%	-10.8%
GMAB	Genmab A/S	-24.6%	8.5%
BBIO	BridgeBio Pharma, Inc.	-39.2%	4999.9%
ROIV	Roivant Sciences Ltd.	-82.9%	-96.1%
SMMT	Summit Therapeutics Inc.	-	-
RGC	Regencell Bioscience Holdings Limited	-	-
RVMD	Revolution Medicines, Inc.	-	-

警語

1. 資料僅供參考，不做任何獲利保證及特定股票與點位推薦建議。

2. 資料並不完整，需要完整資料請至相關網站索取。

3. 任何股市數據分析皆存在倖存者偏差。

醫療類股